1. Home
  2. FCN vs RGEN Comparison

FCN vs RGEN Comparison

Compare FCN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCN
  • RGEN
  • Stock Information
  • Founded
  • FCN 1982
  • RGEN 1981
  • Country
  • FCN United States
  • RGEN United States
  • Employees
  • FCN N/A
  • RGEN N/A
  • Industry
  • FCN Professional Services
  • RGEN Medical/Dental Instruments
  • Sector
  • FCN Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • FCN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • FCN 5.5B
  • RGEN 6.5B
  • IPO Year
  • FCN 1996
  • RGEN N/A
  • Fundamental
  • Price
  • FCN $160.02
  • RGEN $145.83
  • Analyst Decision
  • FCN Hold
  • RGEN Buy
  • Analyst Count
  • FCN 2
  • RGEN 11
  • Target Price
  • FCN $175.50
  • RGEN $167.90
  • AVG Volume (30 Days)
  • FCN 356.9K
  • RGEN 929.7K
  • Earning Date
  • FCN 10-23-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • FCN N/A
  • RGEN N/A
  • EPS Growth
  • FCN N/A
  • RGEN N/A
  • EPS
  • FCN 7.09
  • RGEN N/A
  • Revenue
  • FCN $3,662,887,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • FCN $1.42
  • RGEN $16.77
  • Revenue Next Year
  • FCN $6.21
  • RGEN $13.79
  • P/E Ratio
  • FCN $22.57
  • RGEN N/A
  • Revenue Growth
  • FCN N/A
  • RGEN 8.73
  • 52 Week Low
  • FCN $151.75
  • RGEN $102.97
  • 52 Week High
  • FCN $231.65
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • FCN 40.46
  • RGEN 68.33
  • Support Level
  • FCN $159.12
  • RGEN $121.25
  • Resistance Level
  • FCN $161.42
  • RGEN $125.90
  • Average True Range (ATR)
  • FCN 2.53
  • RGEN 5.31
  • MACD
  • FCN -0.04
  • RGEN 2.79
  • Stochastic Oscillator
  • FCN 43.07
  • RGEN 84.15

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: